FanDuel wants to carve a sports niche in the controversial prediction market business

FanDuel says its prediction market app, FanDuel Predicts, is now available in 16 states and is designed to expand the company’s addressable market ahead of broader state-level sports betting regulation. The core sportsbook remains the company’s main business, with 4 million monthly users across 25 legalized states, but FanDuel is intentionally avoiding sports wagers where its sportsbook already operates. The move positions FanDuel to compete more directly with Kalshi and Polymarket in a fast-growing prediction market category facing heightened regulatory scrutiny and insider-trading concerns.

Analysis

This is less a direct substitute threat to sports betting than a channel-expansion war. FanDuel and DraftKings are effectively using prediction markets to arbitrage state-by-state fragmentation: they can keep premium customer relationships intact while extending reach into states where the core sportsbook is constrained. The second-order winner is CME, which gets a retail distribution layer without having to build consumer acquisition from scratch; that should improve the economics of prediction contracts by lowering CAC and increasing trust.

The bigger issue for DKNG is not immediate revenue cannibalization but margin compression from product parity. If prediction markets become the default legal wrapper for sports-like wagering in non-legal states, the industry shifts from a high-ARPU sportsbook model to a lower-hold, higher-turnover trading model. That matters because the economic moat in sportsbook has been customer acquisition efficiency and pricing discipline; prediction markets reduce both by making the product more fungible and more price-transparent.

The underappreciated regulatory angle is that this may accelerate federal scrutiny, not reduce it. Once sports-adjacent contracts are marketed broadly as trading products, the line between financial speculation and gambling becomes politically harder to defend, especially around elections and geopolitics. A clampdown would likely hit the newest entrants and broad-market platforms first, while established exchange infrastructure providers such as CME retain the option value of being the “clean” venue if the product survives in a narrower form.

Near term, the setup is asymmetric for CME relative to DKNG: CME gets a structurally diversified, regulated growth vector, while DKNG faces a modest but real risk that incremental handle migrates to a lower-cost, more permissive venue. The market may still be underestimating how quickly this becomes a distribution battle rather than a product innovation story.

Key Decisions for Investors

• Long CME / short DKNG as a 3-6 month pair: CME benefits from exchange credibility and regulatory optionality, while DKNG faces margin dilution and potential share loss in non-legal states.
• Buy CME on weakness following any regulatory headline risk: use pullbacks of 3-5% to add, targeting a 6-12 month re-rating if prediction markets remain legally viable.
• Avoid chasing DKNG strength into product-launch enthusiasm; if the stock rallies on prediction-market headlines, fade with tight stops because the valuation uplift is likely to be capped by monetization uncertainty.
• Optionality trade: small long-dated CME calls financed by selling DKNG calls 1-2 strikes above spot, expressing view that regulated exchange distribution is a cleaner winner than sportsbook adjacency.